AIM
ANIK icon

Aigen Investment Management’s Anika Therapeutics ANIK Stock Holding History

Aigen Investment Management’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-9,173
Closed -$325K – 772
2020
Q3 		$325K Sell
9,173
-11,941
-57% -$431K 0.04% 508
2020
Q2 		$797K Buy
21,114
+6,557
+45% +$216K 0.1% 318
2020
Q1 		$421K Buy
14,557
+2,277
+19% +$92.1K 0.06% 486
2019
Q4 		$637K Buy
+12,280
New +$713K 0.11% 274

Other funds holding ANIK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
Boston Trust Walden
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Aigen Investment Management's ANIK Position: Q4 2020 in Review

Aigen Investment Management sold out of Anika Therapeutics (ANIK) in Q4 2020, closing a stake of 9,173 shares — an estimated $325K sold.

Aigen Investment Management first reported a position in ANIK in Q4 2019 and held it in 4 quarters. The position peaked at $797K in Q2 2020. 164 funds tracked by Wall St. Rank hold ANIK as of Q4 2020.

  • Aigen Investment Management reported no remaining Anika Therapeutics position as of Q4 2020 after selling out during the quarter.
  • Aigen Investment Management sold 9,173 Anika Therapeutics shares in Q4 2020, an estimated $325K.
  • Aigen Investment Management first reported a position in Anika Therapeutics in Q4 2019 and held it in 4 quarters.
  • Aigen Investment Management's Anika Therapeutics position peaked at $797K in Q2 2020.
  • 164 funds tracked by Wall St. Rank held Anika Therapeutics as of Q4 2020.

Based on Aigen Investment Management's 13F filing for Q4 2020, filed 12 Feb 2021.